洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR-INR-16010046】保雲療法在治療頸部肌筋膜疼痛成效之前瞻隨機性研究及改善由護士轉介的分流過程

基本信息
登记号

ChiCTR-INR-16010046

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2016-11-24

临床申请受理号

/

靶点

/

适应症

頸部肌筋膜疼痛

试验通俗题目

保雲療法在治療頸部肌筋膜疼痛成效之前瞻隨機性研究及改善由護士轉介的分流過程

试验专业题目

保雲療法在治療頸部肌筋膜疼痛成效之前瞻隨機性研究及改善由護士轉介的分流過程

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

联系人通讯地址
临床试验信息
试验目的

保雲療法在治療頸部肌筋膜疼痛成效之前瞻隨機性研究及改善由護士轉介的分流過程

试验分类
试验类型

随机平行对照

试验分期

治疗新技术

随机化

Randomized control trial

盲法

Single-blind: Investigator/research team

试验项目经费来源

Department of Anaesthesia & Intensive Care, Department of Occupational Therapy, PWH

试验范围

/

目标入组人数

90

实际入组人数

/

第一例入组时间

1990-01-01

试验终止时间

1990-01-01

是否属于一致性

/

入选标准

Consenting adult (age 18-75) with subacute or chronic myofascial neck problem with at least 1 trigger point presents at the neck region, and agrees to discontinue other alternative treatments once giving consent to participate unless approved by the investigators.;

排除标准

Patient refusal, pregnancy, confirmed to be unsuitable to participate by pain specialists due to the presence of urgent or severe co-morbidities or conditions, known severe psychiatric illness, known malignancy, skin disease, infectious disease, severe cardiovascular disease, patients taking anti-coagulants, and patients who are being randomized to receive Bowen therapy (Group 2), receiving concurrent treatment or intervention for pain control such as alternative medicine, physiotherapy, chiropractor, but refuse to discontinue during study period will be excluded.;

研究者信息
研究负责人姓名
试验机构

Department of Anaesthesia & Intensive care, Prince of Wales Hospital, CUHK

研究负责人电话
研究负责人邮箱
研究负责人邮编

/

联系人通讯地址
<END>

Department of Anaesthesia & Intensive care, Prince of Wales Hospital, CUHK的其他临床试验

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品